Key result
An infant developed vaccine-associated paralytic poliomyelitis localized to the limb injected with DTPH, 14 days after receiving the second dose of oral polio vaccine.
Case Report (n=1)
Highlights a rare case of vaccine-associated paralytic poliomyelitis occurring after the second dose of OPV, localized to the site of concurrent DTPH injection.
Vaccine-associated paralytic poliomyelitis (VAPP) is a very rare complication of oral polio vaccine (OPV), seen predominantly with first exposure to OPV. Reversion of vaccine strain poliovirus to a more neurovirulent strain of the virus is thought to be necessary for paralytic disease to occur. Vaccine-associated poliomyelitis can occur in either recipients of the vaccine or in susceptible contacts. We describe an episode of VAPP in an infant in whom paralysis became evident at age 124 days, 14 days after administration of the second dose of OPV vaccine. The second dose of diphtheria-tetanus-pertussis- Haemophilus (DTPH) type-b vaccine had been given at the time of OPV administration, and the hepatitis B vaccine had been administered in the opposite leg. Paralysis was localized to the limb in which the DTPH had been injected.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2000) conducted a case report in Vaccine-associated paralytic poliomyelitis (n=1). Oral polio vaccine (OPV) was evaluated on Paralysis. An infant developed vaccine-associated paralytic poliomyelitis localized to the limb injected with DTPH, 14 days after receiving the second dose of oral polio vaccine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: